GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates
Por:
N. ROCA-AYATS, S. BALCELLS, N. GARCIA-GIRALT, M. FALCO-MASCARO, N. MARTINEZ-GIL, J. ABRIL, R. URREIZTI, J. DOPAZO, J. QUESADA-GOMEZ, X. NOGUES, L. MELLIBOVSKY, D. PRIETO-ALHAMBRA, J. DUNFORD, M. JAVAID, R. RUSSELL, D. GRINBERG and A. DIEZ-PEREZ
Publicada:
4 may 2017
Resumen:
Filiaciones:
N. ROCA-AYATS:
Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain
S. BALCELLS:
Univ Barcelona, Barcelona, Spain
N. GARCIA-GIRALT:
Ctr Invest Biomed Red Fragilidad & Envejecimiento, Barcelona, Spain
M. FALCO-MASCARO:
Univ Barcelona, Barcelona, Spain
N. MARTINEZ-GIL:
Univ Barcelona, Barcelona, Spain
J. ABRIL:
Univ Barcelona, Barcelona, Spain
R. URREIZTI:
CIBERER, Barcelona, Spain
:
CIBERER, Valencia, Spain
J. QUESADA-GOMEZ:
CIBERER, Cordoba, Spain
X. NOGUES:
CIBERFES, Barcelona, Spain
L. MELLIBOVSKY:
Inst Hosp Mar Invest Med, Barcelona, Spain
D. PRIETO-ALHAMBRA:
Univ Oxford, Oxford, England
J. DUNFORD:
Univ Oxford, Oxford, England
M. JAVAID:
Univ Oxford, Oxford, England
R. RUSSELL:
Univ Sheffield, Sheffield, S Yorkshire, England
D. GRINBERG:
CIBERER, Barcelona, Spain
A. DIEZ-PEREZ:
CIBERFES, Barcelona, Spain
|